Do you want to receive the latest myeloma news and research for free, directly in your email inbox? You can with the Myeloma Minute!

Subscribe below to receive weekly email newsletters with up-to-the 'minute' information about multiple myeloma. The Myeloma Minute includes:

  • blogs and videos from Dr. Brian G.M. Durie,
  • inspirational videos,
  • information about drug recalls,
  • research announcements,
  • patient support events,
  • regional educational outreach,
  • advocacy action, and more.
Stay in Touch for the Latest Information
For late breaking news and events, subscribe to the Myeloma Minute!
The January 10, 2019 issue brings news in the new year that will impact the myeloma community. Dr. Brian G.M. Durie highlights this news along with a theme of resilience for 2019.
In the December 13, 2018 issue, IMF Chairman Brian G.M. Durie, MD, sorts through the whirlwind of myeloma research presented at the 2018 Annual Meeting of the American Society of Hematology.
The December 6, 2018 issue features a replay of the IMF's popular IMWG Conference Series, "Making Sense of Treatment," which was recorded at the 2018 American Society of Hematology (ASH) annual meeting and exposition.
The November 29, 2018 issue covers IMF-funded iStopMM project, which IMF Chairman, Brian G.M. Durie, MD reports is "off to a roaring start as it embarks on Year Three."
The November 15, 2018 issue shows how a couple who is affected by multiple myeloma gives back to the myeloma community.
The November 1, 2018 issue covers the ASCENT trial, which evalutates the effectiveness and safety of the combination of Darzalex® (daratumumab) + Kyprolis® (carfilzomib) + Revlimid® (lenalidomide) + dexamethasone in high-risk smoldering multiple myeloma (HRSMM).

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.